Natasha Sigala
Professor of Neuroscience
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (9)
Year:
2026
Year:
2026
Year:
2025
Background: Cognitive training offers a potential approach for the prevention of cognitive decline in later life. Repetition of targeted exercises may improve, or at least preserve, both specific domain and general cognitive abilities by strengthening neural connections and promoting neuroprotective processes within brain networks. Importantly, middle-aged adults have been omitted from the cognitive training literature. In this experiment, we investigated short-term training (1 session) on a perceptual-cognitive-motor task in middle-aged adults. Furthermore, we examined the functional and structural neural correlates of this training. Methods: Twenty-one healthy middle-aged adults between the age of 40 and 50 years underwent one scanning session during which they learned and performed the perceptual-cognitive-motor task. We compared performance and functional imaging on the Early and Late Learning phases of the task. We used diffusion Magnetic Resonance Imaging (MRI) to examine baseline microstructural variation in the brain in relation to training outcome. The diffusion indices included fractional anisotropy (FA), mean diffusivity (MD), neurite density index (NDI), and orientation dispersion index (ODI). Results: We found a significant improvement in performance following training on the task. The improvement correlated with gaming experience, but not with impulsivity. There were also significant training-induced changes in functional activity in cerebellar, cortical and subcortical brain regions. Furthermore, significant correlations were found between the diffusion indices of FA, MD, and ODI and training outcome. Conclusions: These results suggest fast reorganisation of functional activity in the middle-aged brain, and that individual variation in brain microstructure correlates with fast visuo-motor task performance gains.
Year:
2025
Background Schizophrenia is a chronic severe mental illness affecting 24-million people globally, associated with a life expectancy 15 years shorter than the general population. Approximately 70% of people with schizophrenia experience auditory verbal hallucinations (AVHs), i.e. ‘hearing voices’. Current treatment approaches remain unsuccessful in up to 30% of cases. Aims This systematic review and meta-analysis evaluated randomised controlled trials (RCTs) of non-pharmacological treatments for AVHs in schizophrenia spectrum disorders, assessing emerging treatment effectiveness and identifying research gaps. Methods A literature search was performed between 2013-2024 across five databases: PubMed, Embase, PsycINFO, Medline, and Web of Science. The meta-analysis included 45 studies based on predefined criteria and bias assessment. Effect sizes (Hedge’s g) were calculated using a random effects model with 95% confidence intervals. The study followed PRISMA guidelines and was pre-registered (PROSPERO ID: CRD42024598615). Results Our sample included 2,314 patients and fourteen interventions. The overall mean effect size was -0.298 (95% CI, [-0.470, -0.126]), representing a medium, statistically significant effect. Subgroup analyses revealed medium, statistically significant effects for both AVATAR therapy and cognitive behavioural therapy (CBT). Conversely, repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) showed small, non-significant effects. Conclusions AVATAR therapy has the strongest evidence for treating AVHs, highlighting the need for large-scale RCTs and integration into treatment guidelines. CBT requires methodological standardisation. Acceptance and commitment therapy shows promise but needs further high-quality RCTs. Non-invasive brain stimulation techniques require additional trials before clinical implementation.
Year:
2025
Concussions are very common injuries across many different sports and settings and present a significant public health concern in multiple countries. Previous studies have investigated concussion incidence, with a notable number reporting that female athletes have higher rates of sports-related concussions compared to their male counterparts. This study aims to look at risk factors linked to this increased susceptibility of female athletes, and how this affects them, rather than focusing on incidence. To investigate this, we carried out a systematic review following the PRISMA guidelines. We searched the PubMed, Cochrane, APA PsychNet and Web of Science databases Inclusion criteria consisted of papers published in the last 10 years as of the 6th November 2023, studying athletes over the age of 18 who concussed themselves during sporting activity of any level. The exclusion criteria included narrative reviews, single case reports, abstracts, letters to the editor, and studies that included chronic traumatic brain injuries, spinal cord injuries or facial bone fractures. After reviewing all the papers from the search (N= 1373), we identified 27 papers in total that met all inclusion criteria. We then extracted data from each paper relating to the biomechanics, neuropsychology, neurostructural substrates, physiology, and clinical recovery times. The main findings included women having significantly longer recovery times following concussions, increased symptom reporting, and different neurocognitive defects in testing post-concussion compared to men. There was also some evidence to suggest a difference in the neuroinflammatory process between men and women following concussive injury. Highlighting these risk factors can hopefully lead to improved prevention, diagnosis, and treatment for concussions in women’s sports.
Year:
2025
Background Schizophrenia is a chronic severe mental illness affecting 24-million people globally, associated with a life expectancy 15 years shorter than the general population. Approximately 70% of people with schizophrenia experience auditory verbal hallucinations (AVHs), i.e. ‘hearing voices’. Current treatment approaches remain unsuccessful at treating AVHs in up to 30% of cases. Aims This systematic review and meta-analysis evaluated randomised controlled trials (RCTs) of potential non-pharmacological treatments for AVHs in schizophrenia spectrum disorders. The effectiveness of emerging treatments was assessed and gaps in research were identified, with implications for clinical practice. Methods A literature search was performed between 2013-2024 across five databases: PubMed, Embase, PsycINFO, Medline, and Web of Science. The meta-analysis included 45 studies, based on predefined criteria and an assessment for bias. Effect sizes (Hedge’s g) were calculated for each study and overall, using a random effects model with 95% confidence intervals. The study was conducted in accordance with PRISMA guidelines and was pre-registered (PROSPERO ID: CRD42024598615). Results Our sample included 2,314 patients and fourteen different interventions. The calculated overall mean effect size for all interventions was −0.298 (95% CI, [−0.470, −0.126]), representing a medium size and statistically significant effect. Subgroup analyses revealed that both AVATAR therapy and cognitive behavioural therapy (CBT) subgroups had medium size and statistically significant effects. Conversely, repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) showed small size and not statistically significant effects. Conclusions AVATAR therapy has the strongest evidence for treating AVHs, highlighting the need for large-scale RCTs and integration into treatment guidelines. CBT requires standardisation in methodology for reliability, and clinical guidelines should focus on symptomology rather than diagnosis. Acceptance and commitment therapy shows promise but requires further high-quality RCTs. Non-invasive brain stimulation techniques require further trials before they can be considered for clinical use.
Year:
2025
Background Functional neurological disorder (FND) is a heterogeneous condition; severe forms can be disabling. Multidisciplinary treatment and rehabilitation are recommended for severe FND, but there remains a lack of evidence for its efficacy and lack of understanding of the predictors and components of recovery. Methods We report clinical outcome data for an inpatient cohort with severe FND. Clinical Global Impression Improvement with treatment is the primary outcome measure. Admission and discharge measures (Euroqol quality of life measures, Beck Depression Inventory, Spielberger Trait Anxiety Inventory, Cambridge Depersonalisation Scale, Illness Perception Questionnaire (Revised) and Functional Mobility Scale) are reported as secondary outcomes. Results We describe an FND cohort (n=52) with chronic illness (mean symptom duration 9.7 years). At admission, there were clinically relevant levels of depression, anxiety and depersonalisation derealisation. At the time of discharge, most (43/52) patients’ global condition had improved. Measures of mobility, depression and quality of life also significantly improved while at discharge, symptoms were experienced as more understandable and less distressing than at admission. An admission measure of patient confidence in treatment was predictive of eventual clinical outcome. Conclusions The most frequent outcome of inpatient rehabilitation is global improvement, even when symptoms are chronic and severe, reflected in measurable changes in both physical and psychological functioning. Significant levels of depersonalisation derealisation seen in this patient group suggest that routine enquiry into such experiences could help personalise FND treatment approaches. Patient confidence in treatment is key in determining clinical outcomes.
Year:
2024
Year:
2023
Collaborators (4)
Makoto Uji
Research Scientist
RIKEN
Gaby Pfeifer
University of Southampton
Dorina Cadar
Professor in Ageing and Behavioural Science
Brighton and Sussex Medical School
Kata Pauly-Takacs
Senior Lecturer
Leeds Beckett University
Make your next move.
Prepare your application
Review drafts before you send them.